- Home
- JSPR vs DOMH Comparison
JSPR vs DOMH Comparison
Compare JSPR & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- DOMH
- Stock Information
- Founded
- JSPR 2018
- DOMH 1967
- Country
- JSPR United States
- DOMH United States
- Employees
- JSPR N/A
- DOMH N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- JSPR Health Care
- DOMH Health Care
- Exchange
- JSPR Nasdaq
- DOMH Nasdaq
- Market Cap
- JSPR 68.4M
- DOMH 74.0M
- IPO Year
- JSPR N/A
- DOMH N/A
- Fundamental
- Price
- JSPR $1.79
- DOMH $5.45
- Analyst Decision
- JSPR Buy
- DOMH
- Analyst Count
- JSPR 12
- DOMH 0
- Target Price
- JSPR $25.60
- DOMH N/A
- AVG Volume (30 Days)
- JSPR 402.4K
- DOMH 176.3K
- Earning Date
- JSPR 11-10-2025
- DOMH 11-10-2025
- Dividend Yield
- JSPR N/A
- DOMH 9.89%
- EPS Growth
- JSPR N/A
- DOMH N/A
- EPS
- JSPR N/A
- DOMH 9.19
- Revenue
- JSPR N/A
- DOMH $99,588,000.00
- Revenue This Year
- JSPR N/A
- DOMH N/A
- Revenue Next Year
- JSPR N/A
- DOMH N/A
- P/E Ratio
- JSPR N/A
- DOMH $0.54
- Revenue Growth
- JSPR N/A
- DOMH 691.07
- 52 Week Low
- JSPR $1.60
- DOMH $0.83
- 52 Week High
- JSPR $26.05
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- JSPR 33.13
- DOMH 49.20
- Support Level
- JSPR $1.61
- DOMH $4.31
- Resistance Level
- JSPR $1.98
- DOMH $4.92
- Average True Range (ATR)
- JSPR 0.18
- DOMH 0.41
- MACD
- JSPR -0.04
- DOMH 0.04
- Stochastic Oscillator
- JSPR 18.84
- DOMH 61.05
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.